{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:40:29Z","timestamp":1780486829677,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Technology Innovation and Application Development Project of Shapingba, Chongqing, China","award":["2023120"],"award-info":[{"award-number":["2023120"]}]},{"name":"Natural Science Foundation of Chongqing, China","award":["cstc2021jcyj-msxmX0467"],"award-info":[{"award-number":["cstc2021jcyj-msxmX0467"]}]},{"DOI":"10.13039\/100017501","name":"Science-Health Joint Medical Scientific Research Project of Chongqing","doi-asserted-by":"publisher","award":["2024QNXM016"],"award-info":[{"award-number":["2024QNXM016"]}],"id":[{"id":"10.13039\/100017501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017501","name":"Science-Health Joint Medical Scientific Research Project of Chongqing","doi-asserted-by":"publisher","award":["2024ZDXM025"],"award-info":[{"award-number":["2024ZDXM025"]}],"id":[{"id":"10.13039\/100017501","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Project of Chongqing Health Commission Medical Scientific Research","award":["2024WSJK095"],"award-info":[{"award-number":["2024WSJK095"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2021CDJYGRH-014"],"award-info":[{"award-number":["2021CDJYGRH-014"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11096-024-01860-5","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T04:20:36Z","timestamp":1742185236000},"page":"1011-1023","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Developing a machine learning-based predictive model for the analgesic effectiveness of transdermal fentanyl in cancer patients: an interpretable approach"],"prefix":"10.1007","volume":"47","author":[{"given":"Xiaogang","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"issue":"3","key":"1860_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.soncn.2019.04.003","volume":"35","author":"RM Fink","year":"2019","unstructured":"Fink RM, Gallagher E. Cancer pain assessment and neasurement. Semin Oncol Nurs. 2019;35(3):229\u201334.","journal-title":"Semin Oncol Nurs"},{"issue":"3","key":"1860_CR2","first-page":"182","volume":"68","author":"BM Scarborough","year":"2018","unstructured":"Scarborough BM, Smith CB. Optimal pain management for patients with cancer in the modern era. CA Cancer J Clin. 2018;68(3):182\u201396.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"1860_CR3","first-page":"CD012592","volume":"7","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen PJ, Wee B, Derry S, et al. Opioids for cancer pain - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017;7(7):CD012592.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1860_CR4","doi-asserted-by":"publisher","first-page":"11569","DOI":"10.1038\/s41598-020-68348-w","volume":"10","author":"N Qin","year":"2020","unstructured":"Qin N, Shen M, Xiang P, et al. Determination of 37 fentanyl analogues and novel synthetic opioids in hair by UHPLC-MS\/MS and its application to authentic cases. Sci Rep. 2020;10(1):11569.","journal-title":"Sci Rep"},{"issue":"4","key":"1860_CR5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/BF03178274","volume":"5","author":"L Nelson","year":"2009","unstructured":"Nelson L, Schwaner R. Transdermal fentanyl: pharmacology and toxicology. J Med Toxicol. 2009;5(4):230\u201341.","journal-title":"J Med Toxicol"},{"issue":"5","key":"1860_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2165\/00044011-200828050-00005","volume":"28","author":"T Miyazaki","year":"2008","unstructured":"Miyazaki T, Hanaoka K, Namiki A, et al. Efficacy, safety and pharmacokinetic study of a novel fentanyl-containing matrix transdermal patch system in Japanese patients with cancer pain. Clin Drug Investig. 2008;28(5):313\u201325.","journal-title":"Clin Drug Investig"},{"issue":"86\u201387","key":"1860_CR7","first-page":"1545","volume":"55","author":"M Tani","year":"2008","unstructured":"Tani M, Fuku A, Terashita S, et al. Early conversion from oral morphine to transdermal fentanyl in patients with cancer pain. Hepatogastroenterology. 2008;55(86\u201387):1545\u20138.","journal-title":"Hepatogastroenterology"},{"issue":"4","key":"1860_CR8","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1200\/JCO.1998.16.4.1588","volume":"16","author":"R Payne","year":"1998","unstructured":"Payne R, Mathias SD, Pasta DJ, et al. Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine. J Clin Oncol. 1998;16(4):1588\u201393.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1860_CR9","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1089\/jpm.2007.0200","volume":"11","author":"D Tassinari","year":"2008","unstructured":"Tassinari D, Sartori S, Tamburini E, et al. Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: a meta-analysis and systematic review of the literature. J Palliat Med. 2008;11(3):492\u2013501.","journal-title":"J Palliat Med"},{"issue":"2","key":"1860_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1191\/026921600671594561","volume":"14","author":"L Radbruch","year":"2000","unstructured":"Radbruch L, Sabatowski R, Loick G, et al. Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine. Palliat Med. 2000;14(2):111\u20139.","journal-title":"Palliat Med"},{"issue":"15","key":"1860_CR11","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.2165\/00003495-200161150-00014","volume":"61","author":"RB Muijsers","year":"2001","unstructured":"Muijsers RB, Wagstaff AJ. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. Drugs. 2001;61(15):2289\u2013307.","journal-title":"Drugs"},{"issue":"3","key":"1860_CR12","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/0304-3959(95)00180-8","volume":"64","author":"B Donner","year":"1996","unstructured":"Donner B, Zenz M, Tryba M, et al. Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain. Pain. 1996;64(3):527\u201334.","journal-title":"Pain"},{"issue":"1\u20132","key":"1860_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.pain.2009.04.012","volume":"144","author":"T Heiskanen","year":"2009","unstructured":"Heiskanen T, Matzke S, Haakana S, et al. Transdermal fentanyl in cachectic cancer patients. Pain. 2009;144(1\u20132):218\u201322.","journal-title":"Pain"},{"issue":"8","key":"1860_CR14","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/AJP.0b013e3182168fed","volume":"27","author":"Y Kanbayashi","year":"2011","unstructured":"Kanbayashi Y, Hosokawa T, Okamoto K, et al. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain. Clin J Pain. 2011;27(8):664\u20137.","journal-title":"Clin J Pain"},{"issue":"4","key":"1860_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/FPC.0000000000000032","volume":"24","author":"DT Barratt","year":"2014","unstructured":"Barratt DT, Bandak B, Klepstad P, et al. Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study. Pharmacogenet Genom. 2014;24(4):185\u201394.","journal-title":"Pharmacogenet Genom"},{"issue":"18","key":"1860_CR16","doi-asserted-by":"publisher","first-page":"7516","DOI":"10.1002\/cam4.2479","volume":"8","author":"N Moryl","year":"2019","unstructured":"Moryl N, Bokhari A, Griffo Y, et al. Does transdermal fentanyl work in patients with low BMI? Patient-reported outcomes of pain and percent pain relief in cancer patients on transdermal fentanyl. Cancer Med. 2019;8(18):7516\u201322.","journal-title":"Cancer Med"},{"key":"1860_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-024-01818-7","author":"L Pan","year":"2024","unstructured":"Pan L, Mu L, Lei H, et al. Predicting survival benefits of immune checkpoint inhibitor therapy in lung cancer patients: a machine learning approach using real-world data. Int J Clin Pharm. 2024. https:\/\/doi.org\/10.1007\/s11096-024-01818-7.","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"1860_CR18","doi-asserted-by":"publisher","first-page":"E503","DOI":"10.36076\/ppj.2014\/17\/E503","volume":"17","author":"P Gulur","year":"2014","unstructured":"Gulur P, Williams L, Chaudhary S, et al. Opioid tolerance - a predictor of increased length of stay and higher readmission rates. Pain Phys. 2014;17(4):E503\u20137.","journal-title":"Pain Phys"},{"issue":"4","key":"1860_CR19","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1177\/0884533617692527","volume":"32","author":"EI Rabito","year":"2017","unstructured":"Rabito EI, Marcadenti A, Fink JD, et al. Nutritional risk screening 2002, short nutritional assessment questionnaire, malnutrition screening tool, and malnutrition universal screening tool are good predictors of nutrition risk in an emergency service. Nutr Clin Pract. 2017;32(4):526\u201332.","journal-title":"Nutr Clin Pract"},{"issue":"2","key":"1860_CR20","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/bib\/bbz016","volume":"21","author":"JJ Dziak","year":"2020","unstructured":"Dziak JJ, Coffman DL, Lanza ST, et al. Sensitivity and specificity of information criteria. Brief Bioinform. 2020;21(2):553\u201365.","journal-title":"Brief Bioinform"},{"key":"1860_CR21","doi-asserted-by":"publisher","DOI":"10.1037\/met0000601","author":"M Smithson","year":"2023","unstructured":"Smithson M. The receiver operating characteristic area under the curve (or mean ridit) as an effect size. Psychol Methods. 2023. https:\/\/doi.org\/10.1037\/met0000601.","journal-title":"Psychol Methods"},{"issue":"5","key":"1860_CR22","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0885-3924(97)00082-1","volume":"13","author":"S Ahmedzai","year":"1997","unstructured":"Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-fentanyl comparative trial group. J Pain Symptom Manag. 1997;13(5):254\u201361.","journal-title":"J Pain Symptom Manag"},{"issue":"4","key":"1860_CR23","first-page":"599","volume":"39","author":"M Ikeda","year":"2012","unstructured":"Ikeda M, Sonoo H, Kurebayashi J, et al. A pilot study of the reduced effects of adverse events caused by oral morphine and oxycodone after rotating to fentanyl patch in patients with metastatic breast cancer. Gan To Kagaku Ryoho. 2012;39(4):599\u2013603.","journal-title":"Gan To Kagaku Ryoho"},{"issue":"1","key":"1860_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jpainsymman.2004.12.010","volume":"30","author":"T Morita","year":"2005","unstructured":"Morita T, Takigawa C, Onishi H, et al. Opioid rotation from morphine to fentanyl in delirious cancer patients: an open-label trial. J Pain Symptom Manag. 2005;30(1):96\u2013103.","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"1860_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1756-9966-29-67","volume":"29","author":"Q Yang","year":"2010","unstructured":"Yang Q, Xie DR, Jiang ZM, et al. Efficacy and adverse effects of transdermal fentanyl and sustained-release oral morphine in treating moderate-severe cancer pain in Chinese population: a systematic review and meta-analysis. J Exp Clin Cancer Res. 2010;29(1):67.","journal-title":"J Exp Clin Cancer Res"},{"key":"1860_CR26","first-page":"CD010270","volume":"10","author":"G Hadley","year":"2013","unstructured":"Hadley G, Derry S, Moore RA, et al. Transdermal fentanyl for cancer pain. Cochrane Database Syst Rev. 2013;10:CD010270.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"1860_CR27","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/jjco\/hym017","volume":"37","author":"KE Clemens","year":"2007","unstructured":"Clemens KE, Klaschik E. Clinical experience with transdermal and orally administered opioids in palliative care patients\u2013a retrospective study. Jpn J Clin Oncol. 2007;37(4):302\u20139.","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"1860_CR28","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1248\/bpb.b19-01086","volume":"43","author":"T Chiba","year":"2020","unstructured":"Chiba T, Takahashi H, Tairabune T, et al. Cancer cachexia may hinder pain control when using fentanyl patch. Biol Pharm Bull. 2020;43(5):873\u20138.","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"1860_CR29","first-page":"149","volume":"122","author":"A Reddy","year":"2016","unstructured":"Reddy A, Tayjasanant S, Haider A, et al. The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients. Cancer-Am Cancer Soc. 2016;122(1):149\u201356.","journal-title":"Cancer-Am Cancer Soc."},{"key":"1860_CR30","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2147\/TCRM.S79374","volume":"11","author":"M Suno","year":"2015","unstructured":"Suno M, Endo Y, Nishie H, et al. Refractory cachexia is associated with increased plasma concentrations of fentanyl in cancer patients. Ther Clin Risk Manag. 2015;11:751\u20137.","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"1860_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2024.03.019","volume":"68","author":"M Davis","year":"2024","unstructured":"Davis M. Fentanyl pharmacokinetic paradoxical in cancer cachexia. J Pain Symptom Manag. 2024;68(1): e78.","journal-title":"J Pain Symptom Manag"},{"issue":"9","key":"1860_CR32","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/S0090-9556(25)07486-0","volume":"24","author":"DE Feierman","year":"1996","unstructured":"Feierman DE, Lasker JM. Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4. Drug Metab Dispos. 1996;24(9):932\u20139.","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"1860_CR33","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.2165\/11635500-000000000-00000","volume":"72","author":"M Bosilkovska","year":"2012","unstructured":"Bosilkovska M, Walder B, Besson M, et al. Analgesics in patients with hepatic impairment: pharmacology and clinical implications. Drugs. 2012;72(12):1645\u201369.","journal-title":"Drugs"},{"issue":"4","key":"1860_CR34","first-page":"1029","volume":"14","author":"I Solassol","year":"2005","unstructured":"Solassol I, Caumette L, Bressolle F, et al. Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patients. Oncol Rep. 2005;14(4):1029\u201336.","journal-title":"Oncol Rep"},{"issue":"1","key":"1860_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/AJP.0b013e31817e1379","volume":"25","author":"Y Kanbayashi","year":"2009","unstructured":"Kanbayashi Y, Okamoto K, Ogaru T, et al. Statistical validation of the relationships of cancer pain relief with various factors using ordered logistic regression analysis. Clin J Pain. 2009;25(1):65\u201372.","journal-title":"Clin J Pain"},{"issue":"Suppl 1","key":"1860_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2165\/00003088-200544001-00005","volume":"44","author":"SK Gupta","year":"2005","unstructured":"Gupta SK, Hwang S, Southam M, et al. Effects of application site and subject demographics on the pharmacokinetics of fentanyl HCl patient-controlled transdermal system (PCTS). Clin Pharmacokinet. 2005;44(Suppl 1):25\u201332.","journal-title":"Clin Pharmacokinet"}],"updated-by":[{"DOI":"10.1007\/s11096-025-01921-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000}}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01860-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-024-01860-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01860-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T08:04:11Z","timestamp":1757145851000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-024-01860-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1860"],"URL":"https:\/\/doi.org\/10.1007\/s11096-024-01860-5","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s11096-025-01921-3","asserted-by":"object"}]},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The term BMI2 has been corrected as BMI in the Results subsection of the Abstract","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11096-025-01921-3","URL":"https:\/\/doi.org\/10.1007\/s11096-025-01921-3","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}